Jia-Hao Law1, Huilin Shao2,3,4,5, Ramanuj DasGupta6

  • 1Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, National University Hospital, Singapore.

概括

肝细胞癌 (HCC) 复发是一个重大挑战. 先进的生物标志物和人工智能分析可以改善风险预测和个性化治疗,以获得更好的患者结果.

相关概念视频